Navigation Links
PCMA: Some Drugmakers Lobbying to Limit E-Prescribing of Generics, Drug Safety Checks
Date:2/10/2011

WASHINGTON, Feb. 10, 2011 /PRNewswire-USNewswire/ -- Some drug manufacturers are aggressively pushing legislative proposals in states across the country that if enacted would undermine electronic prescribing's (e-prescribing) proven safety and savings benefits, the Pharmaceutical Care Management Association (PCMA) said today.

"This campaign undermines e-prescribing's two main goals: improving patient safety and reducing prescription drug costs. Doctors should be able to check for dangerous drug-drug interactions and help patients find affordable options," said PCMA President and CEO Mark Merritt.

E-prescribing provides physicians with clinical and cost information on prescription options that allows them to better counsel patients on which medications – including various lower cost alternatives – will be the safest and most affordable choices. The e-prescribing framework was passed by the federal government in 2003 in the Medicare Modernization Act (MMA).

Subsequently, the 2008 Medicare Improvements for Patients and Providers Act (MIPPA) and the 2009 Health Information Technology for Economic and Clinical Health Act (HITECH) both established clear benchmarks that require physicians to use e-prescribing technology as part of fully functional health information technology (HIT) systems.

Specifically the state-based legislation would undermine e-prescribing's progress by:

  • Prohibiting doctors from seeing all lower cost options such as cheaper generics and preferred brands.
  • Preventing the technology from showing safety information such as drug-drug interactions.
  • Disallowing any choice of lower cost pharmacy options.

Legislation is currently pending in 11 states. Those states are: Indiana, Kansas, Mississippi, Missouri, Nebraska, New Mexico, New Jersey, North Dakota, Oklahoma, Pennsylvania, and South Dakota.

PCMA represents the nation's pharmacy benefit managers (PBMs), which improve affordability and quality of care through the use of electronic prescribing (e-prescribing), generic alternatives, mail-service pharmacies, and other innovative tools for 200-plus million Americans.

Follow PCMA on Twitter


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PCMA: Independent Drugstore Lobby Continues Disclosure Double Standard Transparency Campaign
2. PCMA: Ohios Medicaid Program Could Save $135 Million
3. PCMA: Focus on Patients, Not Profits, in Medicaid Pharmacy
4. PCMA: Florida Could Reduce $462 Million in Wasteful Medicaid Pharmacy Spending
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy With No Dose Limiting Toxicity in Metastatic Pancreatic Cancer
7. Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions
8. New Bisphenol A Study Has Limited Capability to Assess Human Health Effects
9. Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery
10. New Bisphenol A Study Is of Very Limited Relevance to Human Health
11. Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... NEW YORK , May 4, 2016 ... Size, Share, Development, Growth and Demand Forecast to 2022 - ... End User (Hospital, Diagnostic Center and Others)" by P&S Market ... at $4,894.3 million in 2015, and it is expected to ... slice type, the high slice type segment is expected to ...
(Date:5/4/2016)... May 4, 2016 ... the  "Global Multiple Myeloma Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... and Competitive Landscape Highlights 2016, provides comprehensive ... Myeloma epidemiology, Multiple Myeloma market valuations and ...
(Date:5/4/2016)... May 4, 2016 ... the  "Global Acute lymphocytic Leukemia Market and ... their offering.       (Logo: ... Lymphocytic Leukemia Market and Competitive Landscape Highlights ... Leukemia pipeline products, Acute Lymphocytic Leukemia epidemiology, ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... May 05, 2016 , ... TIME for Kids and The ZAC ... a new partnership to reach nearly 1 million children with important water safety messages ... is the leading cause of accidental death in children one to 6 years of ...
(Date:5/5/2016)... ... 05, 2016 , ... The 2016 Nike Soccer Camp will be directed by ... coaching staff. Together they bring their winning Vandals coaching philosophy to young athletes. Programs ... 5-13, and high school players. Session dates are as follows: , Youth Day Camp ...
(Date:5/5/2016)... ... May 05, 2016 , ... United Collection Bureau, Inc. (UCB) announces ... more than 15 years of experience within the healthcare revenue cycle industry. With a ... the Director of Patient Financial Services at Spectrum Health. While at Spectrum Health, Clark ...
(Date:5/5/2016)... , ... May 05, 2016 , ... ... honored finalists and winners Tuesday evening, May 3, at the 2016 ISE® Central ... , Scott Pettigrew, Vice President and Chief Security Officer of HMS, was selected ...
(Date:5/5/2016)... ... May 05, 2016 , ... ACLS Certification Institute, a ... new referral program, giving participants incentive for spreading the word about the Institute’s ... know many professionals share resources with their friends and colleagues,” said Vonda Andrews, ...
Breaking Medicine News(10 mins):